Deciding on a Fill-Finish CDMO is a Strategic Decision If capacity and cost are the first metrics you, as the...
What to Expect As biologics manufacturing evolves, Contract Development and Manufacturing Organizations (CDMOs) are becoming increasingly pivotal. At CPHI Milan,...
As biologic therapies continue to reshape pharmaceutical development, the demands placed on sterile fill-finish manufacturing have never been higher. Pharmaceutical...